Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer

Publication date: 18 July 2017
Source:Cell Reports, Volume 20, Issue 3
Author(s): Jung-Eun Jang, Cristina H. Hajdu, Caroline Liot, George Miller, Michael L. Dustin, Dafna Bar-Sagi
Regulatory T (Treg) cell infiltration constitutes a prominent feature of pancreatic ductal adenocarcinoma (PDA). However, the immunomodulatory function of Treg cells in PDA is poorly understood. Here, we demonstrate that Treg cell ablation is sufficient to evoke effective anti-tumor immune response in early and advanced pancreatic tumorigenesis in mice. This response is dependent on interferon-γ (IFN-γ)-producing cytotoxic CD8⁺ T cells. We show that Treg cells engage in extended interactions with tumor-associated CD11c⁺ dendritic cells (DCs) and restrain their immunogenic function by suppressing the expression of costimulatory ligands necessary for CD8⁺ T cell activation. Consequently, tumor-associated CD8⁺ T cells fail to display effector activities when Treg cell ablation is combined with DC depletion. We propose that tumor-infiltrating Treg cells can promote immune tolerance by suppressing tumor-associated DC immunogenicity. The therapeutic manipulation of this axis might provide an effective approach for the targeting of PDA.

Graphical abstract

Teaser

Pancreatic tumors recruit dendritic cells that can switch between preventing or promoting immune responses. Jang et al. show that regulatory T cells are responsible for instructing the dendritic cells to prevent anti-tumor immunity. Removing the regulatory T cell subset allows dendritic cells to induce a potent anti-tumor immune response.


from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uxOIua
via IFTTT